GHRH analog comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-27. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
| Property | Value | Notes |
|---|---|---|
| Primary target | Growth hormone-releasing hormone receptor | Located on anterior pituitary somatotroph cells. |
| Receptor class | G protein-coupled receptor | Activation increases intracellular cyclic AMP. |
| Main downstream hormone | Growth hormone and insulin-like growth factor 1 | Growth hormone release precedes IGF-1 elevation. |
| Primary studied effect | Reduction in visceral adipose tissue | Measured by computed tomography in clinical trials. |
| Approximate half-life | 26–38 minutes after subcutaneous administration | Values vary by assay and study population. |
Lyophilized material is typically held under refrigeration between two and eight degrees Celsius, shielded from light and ambient moisture. Peptides of this size adsorb to glass and plastic, so working procedures often call for low-binding containers and as few transfers as possible. Absorbed water during weighing shifts the apparent mass of a sample, and controlling room humidity reduces that source of error. Once dissolved, solutions are kept cold and used within the interval printed on the accompanying label or certificate. Degradation accelerates markedly in dilute aqueous form.
Identity and purity are judged through a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact peptide from truncated, oxidized, and deamidated variants, and the resulting peak-area percentages yield a purity figure. Electrospray ionization mass spectrometry confirms the expected molecular mass and can expose unanticipated modifications. Amino acid analysis and peptide mapping support sequence fidelity, while water content, pH, sterility, and bacterial endotoxin testing describe the physical and microbiological attributes of a finished lot.
Regulatory position depends on jurisdiction and on the form in which the material is sold. A branded product holds approval in the United States for a defined indication, and prescribing is confined to that label. Material marketed for laboratory research is not evaluated for human use and carries no such clearance. Independent verification therefore rests on certificates of analysis, third-party testing, and documented chain of custody. The substance also appears on the World Anti-Doping Agency prohibited list within the category covering growth hormone-releasing factors.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
Though his administration successfully reached its target of vaccinating 70% of the Philippine population, Duterte, along with Health Secretary Francisco Duque III, was implicated in a scandal involving allegedly overpriced medical supplies and equipment. Critics highlighted that Duterte's administration purchased pandemic supplies from Pharmally Pharmaceutical, a company linked to Duterte's former economic adviser, Michael Yang. Duterte rejected the corruption allegations and emphasized that the supplies at the time of purchase were in high demand, hence, the high prices. A Senate probe, headed by Senate Blue Ribbon Committee chairman Richard Gordon, was initiated in August 2021 for alleged irregularities in the use of COVID-19 response funds amounting to ₱67 billion. A month before Duterte left office, Gordon released a draft report on the probe, which claimed that Duterte "betrayed public trust" for appointing Yang as economic adviser in 2018, prohibited his Cabinet and other officials from attending the hearings, and allegedly discredited the Senate and Commission on Audit. The report, however, failed to reach the Senate plenary for deliberation after it was signed by nine senators out of the 11 required signatures.
=== Early history === The origins of algorithmically generated media can be traced to the development of the Markov chain, which has been used to model natural language since the early 20th century. Russian mathematician Andrey Markov introduced the concept in 1906, including an analysis of vowel and consonant patterns in Eugene Onegin. Once trained on a text corpus, a Markov chain can generate probabilistic text. By the early 1970s, artists began using computers to extend generative techniques beyond Markov models. Harold Cohen developed and exhibited works produced by AARON, a pioneering computer program designed to autonomously create paintings. The terms generative AI planning or generative planning were used in the 1980s and 1990s to refer to AI planning systems, especially computer-aided process planning, used to generate sequences of actions to reach a specified goal. Generative AI planning systems used symbolic AI methods such as state space search and constraint satisfaction and were a "relatively mature" technology by the early 1990s. They were used to generate crisis action plans for military use, process plans for manufacturing and decision plans such as in prototype autonomous spacecraft.
It was definitively accepted by the Fédération Cynologique Internationale in 1954. In the fifteen years from 2007 to 2021, the annual number of new registrations in Germany averaged about 485, with a low of 390 and a high of 607.
In January 2018, a class action lawsuit was filed against LifeVantage in Connecticut alleging that the company and its chief executive officer Darren Jensen, chief sales officer Justin Rose, and chief marketing officer Ryan Goodwin were operating an illegal pyramid scheme in violation of the RICO Act, federal securities laws, and the Connecticut Unfair Trade Practices Act.
Sources: en.wikipedia.org
{\displaystyle {\frac {[\mathrm {cyt~c_{red}} ]}{[\mathrm {cyt~c_{ox}} ]}}=\left({\frac {[\mathrm {NADH} ]}{[\mathrm {NAD} ]^{+}}}\right)^{\frac {1}{2}}\left({\frac {[\mathrm {ADP} ][\mathrm {P_{i}} ]}{[\mathrm {ATP} ]}}\right)K_{\mathrm {eq} }}
=== Mechanical equivalent of heat === A key stage in the development of the modern conservation principle was the demonstration of the mechanical equivalent of heat. The caloric theory maintained that heat could neither be created nor destroyed, whereas conservation of energy entails the contrary principle that heat and mechanical work are interchangeable. In the middle of the eighteenth century, Mikhail Lomonosov, a Russian scientist, postulated his corpusculo-kinetic theory of heat, which rejected the idea of a caloric. Through the results of empirical studies, Lomonosov came to the conclusion that heat was not transferred through the particles of the caloric fluid. In 1798, Count Rumford (Benjamin Thompson) performed measurements of the frictional heat generated in boring cannons and developed the idea that heat is a form of kinetic energy; his measurements refuted caloric theory, but were imprecise enough to leave room for doubt.
==== Negative selection ==== Negative selection removes thymocytes that are capable of strongly binding with "self" MHC molecules. Thymocytes that survive positive selection migrate towards the boundary of the cortex and medulla in the thymus. While in the medulla, they are again presented with a self-antigen presented on the MHC complex of medullary thymic epithelial cells (mTECs). mTECs must be Autoimmune regulator positive (AIRE+) to properly express tissue-specific antigens on their MHC class I peptides. Some mTECs are phagocytosed by thymic dendritic cells; this makes them AIRE− antigen presenting cells (APCs), allowing for presentation of self-antigens on MHC class II molecules (positively selected CD4+ cells must interact with these MHC class II molecules, thus APCs, which possess MHC class II, must be present for CD4+ T-cell negative selection). Thymocytes that interact too strongly with the self-antigen receive an apoptotic signal that leads to cell death. However, some of these cells are selected to become Treg cells. The remaining cells exit the thymus as mature naive T cells, also known as recent thymic emigrants. This process is an important component of central tolerance and serves to prevent the formation of self-reactive T cells that are capable of inducing autoimmune diseases in the host.
Sources: en.wikipedia.org
In addition, they also used petroleum to cover their bodies against insect bites and as a form of jelly to prevent their skins from drying out. Peyote – indigenous people realized the antibiotic property of peyote and used the extract to treat fevers and enhance the energy in their bodies and treatment as an anesthetic. Pineapple – indigenous people residing in what is now Brazil and the Paraná River valley of Paraguay were the first to cultivate the pineapple. From there, pineapple cultivation spread to Mexico, Central and South America and the Caribbean. Indigenous Americans used the pineapple as a source of food. Planned city construction – ancient cities in Mexico–such as Teotihuacan and the Aztec capital of Tenochtitlan–incorporated planned city design, including streets laid out in a grid pattern. Plumbing – the Maya have been found to be the earliest inventors of plumbing in Mesoamerica, with the earliest example of a pressurized water system being constructed in 750 CE—or earlier. This pressurized water system was located in the Maya site of Palenque, where public baths and toilets were accessible to the residents of the ancient city. Poncho – worn by indigenous Americans in central Mexico, the Andes and Patagonia. Popcorn – Indigenous Americans were among the earliest peoples to develop popcorn, with evidence of popcorn dating back thousands of years in the Americas. Potato – The potato was domesticated 7,000–10,000 years ago in the highlands of southern Peru and northwestern Bolivia near Lake Titicaca.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy (CSII = Continuous Subcutaneous Insulin Infusion). The device configuration may vary depending on design. A traditional pump includes:
Other adaptations of tuna for speed include a streamlined, spindle-shaped body, fins designed to reduce drag, and muscles with a raised myoglobin content, which gives these a reddish colour and makes for a more efficient use of oxygen. In polar regions and in the deep ocean, where the temperature is a few degrees above freezing point, some large fish, such as the swordfish, marlin and tuna, have a heating mechanism which raises the temperature of the brain and eye, allowing them significantly better vision than their cold-blooded prey.
== Advertising == The company owns two blimps: the Bloomin' Onions I and II, both named after their appetizer. For several years, the company ran a media campaign with an Australian-themed variation of the Of Montreal composition "Wraith Pinned to the Mist (And Other Games)." General (Ret) Tommy Franks sits on the Board Of Directors for OSI Restaurant Partners, INC., which owns Outback Steakhouse.
Sources: en.wikipedia.org
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.
It does not act directly on adipose tissue as a primary mechanism. Instead, it increases endogenous growth hormone, which then influences lipolysis and fat distribution. The reduction in visceral fat is an indirect pharmacodynamic effect.
Tesamorelin acts upstream at the pituitary to amplify natural pulsatile growth hormone release. Growth hormone injections provide exogenous hormone and bypass pituitary regulation. The two approaches therefore differ in feedback control and hormonal dynamics.
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.